A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during the SITC annual meeting.

This success suggests that the complex interactions between therapeutic cells and their targets could lead to innovative treatments for both autoimmune diseases and cancer. Initial trials using CAR T ...

People living with the disease have been given hope of lifelong relief by a new cell therapy which has had successful results ...

As the new year is here, take a look at some of the most common New Year's resolutions, with tips on how to follow through ...

UC San Francisco treated its first brain cancer patient with an experimental new CAR-T therapy discovered and manufactured at ...

New Phase 1/2 data support the potential of our CAR T-cell therapy candidates, GLPG5101 and GLPG5201, in addressing unmet needs for patients with ...

BMW’s electric future is taking shape on the outskirts of the Mexican city of San Luis Potosi, some 450 miles south of the ...

A battery pack manufacturer has released a new solution for Tesla Roadster with aging battery packs. It would slash ...

I've ridden long-haul Amtrak trains around the US, so I've encountered my fair share of problems. Here's how I prepare for ...

As a hydrogen SUV, the Hyundai Initium likely previews a replacement for the current Hyundai Nexo, which is capable of 350 to ...

A growing body of research suggests that clinicians can offer chimeric antigen receptor (CAR) T-cell therapy safely and ...